Find out how hormone replacement therapy and hormonal contraceptives affect a woman’s risk of cancer. Plus read on to order a free copy of our Women’s health guide.
On this page
Hormone therapies, including hormone replacement therapy (HRT) and hormonal contraceptives such as the combined contraceptive pill (also known as the Pill), play important roles in women’s health. While these treatments offer many benefits, there are also concerns about their potential impact on cancer risk. This page aims to provide the information you need to help you make informed decisions about your health.
What is HRT?
HRT is a treatment used to ease symptoms of the menopause by replacing hormones that naturally decline during this phase of life. It mainly contains oestrogen, often combined with progesterone (known as combined HRT). You can take HRT in various forms, including tablets, skin patches, gels, spray, pessaries or cream.
What is the Pill and other hormonal contraceptives?
Hormonal contraceptives are used for birth control (preventing pregnancy) and managing other health conditions. They come in various forms:
- combined pill (contains oestrogen and progesterone)
- mini-pill (contains progesterone only)
- contraceptive patches (contains oestrogen and progesterone)
- hormonal coil (contains progesterone only)
- hormonal implant (contains progesterone only)
- contraceptive injections (contains progesterone only)
HRT and cancer risk
We explore the links between taking HRT and a woman’s risk of cancer.
Breast cancer
Taking combined HRT can slightly increase risk of breast cancer. Using oestrogen-only HRT shows little or no increase in risk. The longer HRT is used and the older someone is, the greater the risk. But after HRT is stopped, risk gets smaller over time.
Womb cancer
Oestrogen-only HRT increases the risk of womb cancer. This is why it’s usually only prescribed for women who have had a hysterectomy (removal of the womb).
Ovarian cancer
Both oestrogen-only and combined HRT show a slight increased risk. The risk seems to reduce after stopping treatment.
Bowel cancer
Some evidence suggests HRT may lower the risk of bowel cancer, although more research is needed to confirm this.
Hormonal contraceptives and cancer risk
We explore the links between taking hormonal contraceptives and a woman’s risk of cancer.
Breast cancer
The Pill and mini–pill slightly increases breast cancer risk. Within a few years of stopping, the risk disappears to as if it was never used.
Cervical cancer
The Pill may slightly increase the risk of cervical cancer and the risk can increase the longer it is used. Within a few years of stopping, the risk disappears as if it was never used. The evidence is not as strong as for breast cancer and more research is needed.
Ovarian, womb and bowel cancers
Evidence suggests that the Pill may lower the risk of these cancers.
The science behind hormone therapies and cancer
- The increased cancer risks associated with hormone therapies are generally small.
- For many women, the benefits of these hormone treatments are far greater than the risks.
The relationship between hormone therapies and cancer risk is complex and still being studied.
Hormones like oestrogen and progesterone can affect the growth of certain cancer cells – this may explain the slight increased risks. But these hormones also play an important part in keeping us healthy. This is why treatments like HRT can have a number of benefits.
It’s important to note that much of the research on HRT and cancer risk is based on older studies. These studies used different formulations than those commonly prescribed today. Newer hormones that are more similar to our own body may have different health effects, and research is ongoing.
Our conclusion
While hormone therapies like HRT and hormonal contraceptives may slightly increase the risk of certain cancers, these risks are generally small and often outweighed by the benefits for many women. It’s important not to use HRT for more than 5 years.
Discuss your personal situation and medical history with your doctor to make the best decision for your health. For more information and support in the UK, visit the NHS website for HRT and hormonal contraception. Recommendations may vary depending on the country.
Remember, the best way to reduce your overall cancer risk is by eating well, keeping active, keeping a healthy weight, avoiding smoking and keeping safe in the sun.
Women’s health guide
Find out the facts and stay in control of your health with our free booklet
Find out more
Sources and references
- HRT and cancer references
- NHS: Benefits and risks of HRT
- Breast Cancer Now: HRT and breast cancer risk
- Cancer Research UK: Does hormone replacement therapy (HRT) increase the risk of cancer?
- National Institute for Health and Care Excellence (NICE): Long-term benefits and risks of HRT
- Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (2019).
- Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis (2019).
- Hormone replacement therapy and the risk of endometrial cancer: A systematic review. (2016).
- The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer (2011).
- Hormonal contraceptives and cancer references
- NHS: Side effects and risks of the combined contraceptive pill
- NHS: Side effects and risks of the progesterone-only pill
- Breast Cancer Now: The pill, contraception and breast cancer risk
- Cancer Research UK: Does the contraceptive pill increase risk of cancer?
- Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case–control study and meta-analysis (2023).
- Oral contraceptives use and risk of cervical cancer – A systematic review & meta-analysis (2020).
- Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies (2015).
- Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis (2013).
- Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis (2009).
Explore the evidence and reduce your risk
Breast cancer
Breast cancer
1 in 8 women will develop breast cancer in their lifetime
More on breast cancer
Prostate cancer
Prostate cancer
African-Caribbean and African men have a higher risk of prostate cancer
More on prostate cancer
Liver cancer
Liver cancer
Drinking alcohol and being overweight or obese increase the risk
More on liver cancer
Preventing cancer. Saving lives
While society continues to search for a cure, our prevention and survival work helps people to live longer, healthier lives – free from the devastating effects of cancer.